Travere Therapeutics, Inc. (0001438533) (Filer) — SEC 8-K Filing
Travere Therapeutics
May 11, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Florida State University is set to acquire Tallahassee Memorial HealthCare. The transaction is classified as a divestiture and is currently in announced status.
The deal is tied to the healthcare services sector and is associated with Florida, with the Tallahassee Memorial HealthCare name indicating a local hospital footprint in the Tallahassee area.
Filed under
Source
Read full article on beckershospitalreview.comvia Beckers Hospital Review - All · March 27, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Travere Therapeutics
May 11, 2026
Pharvaris
May 11, 2026
Partner Therapeutics→Bizengri (bispecific antibody)
May 11, 2026
The Surgery Center of Southern Oregon
May 11, 2026
Mobia Medical
May 11, 2026